Beijing and Shanghai-based Medbanks, an information service provider specializing in cancer care, has raised RMB400 million ($59 million) in Series C funding led by CLP Fund.
Sequoia Capital China and HighLight Capital have led a RMB550 million ($80 million) pre-IPO funding round for BrightGene Bio-Medical Technology, a Chinese developer of innovative and generic drugs. An investment unit of GF Securities also participated.
Sequoia Capital India has led a $40 million Series C funding round for Eruditus Executive Education, a developer of education technology based in India, with participation by existing investor Bertelsmann India Investments.
Chinese drug developer Antengene wins backing from the likes of Boyu Capital and FountainVest Partners for a pipeline of treatments that address the country's growing cancer problem
GIC Private has invested in Vietcombank through a joint deal with Mizuho Bank worth VND6.2 trillion ($265 million), underlining the strong interest among private and strategic investors in Vietnam’s financial sector.
SunBridge Partners, a US-based VC firm that helps companies access Japan, has exited its position in a Japanese joint venture (JV) with B2B cloud technology provider Marketo to Adobe.
Chinese online healthcare services provider Zhiyun Health has raised $100 million in a Series C round of funding across two tranches.
Nreal, a China-based company that makes advanced virtual reality glasses that resemble normal sunglasses, has raised $15 million in Series A funding from investors including Shunwei Capital.
Ming Maa, president of Grab, explains how the transformation of a taxi-hailing start-up into a diversified technology heavyweight reflects ongoing confidence in Southeast Asia’s economic future
VC fundraising has been on a roll in Asia as managers raise larger sums to address fast-growing investment opportunities. GPs must consider what – and how much – makes them stand out from the crowd
360 Enterprise Security, a Chinese B2B internet security software provider that spun-out from Qihoo 360, has closed a Series B round of funding worth RMB900 million ($132 million), achieving a valuation of RMB20.6 billion.
Sanjiv Kaul, who left a career with pharma giant Ranbaxy to become an investor at ChrysCapital Partners, discusses the evolution of operational capabilities in Indian private equity
Aion Capital Partners, a special situations joint venture between Apollo Global Management and ICICI Venture, has acquired Interglobe Technologies (IGT), the business process outsourcing (BPO) division of Indian travel conglomerate Interglobe Enterprises.
China Everbright has reached a final close of $539 million on its cross-border investment fund, with the commitments coming from corporate investors, family offices, and fund-of-funds.
Indian managed accommodation platform operator Zolo has raised $30 million in Series B funding from a group of investors including IDFC Alternatives.
China-based healthcare care services provider Miaoshou Doctor has raised RMB500 million ($72.8 million) in an extended Series C round of funding led by Starquest Capital, with participation from Sequoia Capital China.
China’s Loyal Valley Capital has led a $160 million funding round for Beijing Innocare, a biotechnology developer focused on immuno-oncology and autoimmune diseases.
Platinum Equity has agreed to buy PCI, a Singapore-listed electronics manufacturer owned by local conglomerate Chuan Hup Holdings, for S$203 million ($150 million).
WeRide.ai, a Chinese autonomous driving technology specialist formerly known as Jingchi.ai, has raised several hundred millions of US dollars in an extended Series A round led by local artificial intelligence (AI) company SenseTime.
New Alliance Capital has led a $45 million Series A round for China-based contract research and manufacturing services provider Thousand Oaks Biopharmaceuticals, with participation by Addor Capital and several other healthcare-focused investors.
Baraja, an Australia-based start-up developing guidance technology for autonomous vehicles, has raised a $32 million Series A round from investors including Sequoia China and Blackbird Ventures.
Chinese commercial rocket developer iSpace has completed an extended Series A round of undisclosed size led by CDH Investments, with participation from Matrix Partners China and local VC Dianke Xinghe.
Indian venture capital firm Iron Pillar Capital Management has led a $22 million Series D round for Vyome Therapeutics, a domestic pharmaceuticals developer focused on skin diseases.
Indian online automobile marketplace CarDekho has raised $110 million in Series C funding from investors including Sequoia Capital India, Hillhouse Capital, CapitalG – an investment arm of Alphabet, parent of Google – and Axis Bank.